Treatment and prevention of stroke in children with sickle cell disease

Current Treatment Options in Neurology

Volumn 8, Issue 6, 2006, Pages 503-512

  Mehta, Shyamal H ^b   Adams, Robert J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEMOGLOBIN S; HYDROXYUREA; LOW MOLECULAR WEIGHT HEPARIN; NIFEDIPINE; TISSUE PLASMINOGEN ACTIVATOR;

ANEURYSM RUPTURE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; DISABILITY; DOPPLER ECHOGRAPHY; EXCHANGE BLOOD TRANSFUSION; HIGH RISK PATIENT; HUMAN; MOYAMOYA DISEASE; PRIMARY PREVENTION; REHYDRATION; SECONDARY PREVENTION; SICKLE CELL ANEMIA; STROKE;

EID: 33750623537     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0040-8     Document Type: Article

References (37)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288-294.
2. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ: Sickle cell disease: the neurologic complications. Ann Neurol 2002, 51:543-552.
3. Moser FG, Miller ST, Bello JA, et al.: The spectrum of brain MR abnormalities in sickle cell disease: a report from the co-operative study of sickle cell disease. Am J Neuroradiol 1996, 17:965-972.
4. Powars DF, Conti PS, Wong WY, et al.: Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood 1999, 93:71-79.
5. Adams RJ, Nichols FT, McKie V, et al.: Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988, 38:1012-1017.
6. Preul MC, Cendes F, Just N, Mohr G: Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998, 42:971-977.
7. Pegelow CH: Stroke in children with sickle cell anemia: aetiology and treatment. Paediatr Drugs 2001, 3:421-432.
8. Ng WH, Yeo TT, Seow WT: Non-traumatic spontaneous acute epidural hematoma - report of two cases and review of the literature. J Clin Neurosci 2004, 7:791-794.
9. Hoppe C, Klitz W, Cheng S, et al.: Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004, 103:2391-2396.
10. Hoppe C, Klitz W, Noble J, et al.: Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 2003, 101:2865-2869.
11. Platt OS: Preventing stroke in sickle cell anemia. N Engl J Med 2005, 353:2743-2745.
12. Ware RE, Zimmerman SA, Sylvestre PB, et al.: Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004, 145:346-352.
13. Kirkham Fj, deBaun MR: Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004, 6:357-375.
14. Nowak-Gottl U, Straeter R, Sebire G, Kirkham F: Antithrombotic drug treatment of pediatric patients with ischemic stroke. Paediatr Drugs 2003, 5:167-175.
15. Soman T, Rafay MF, Hune S, et al.: The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 2006, 37:1120-1122.
16. Thirumalai SS, Shubin RA: Successful treatment of stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000, 15:558.
17. Anson JA, Koshy M, Ferguson L, et al.: Subarachnoid hemorrhage in sickle cell disease. J Neurosurg 1991, 75:552-558.
18. Vicari P, Choairy CC, Siufi GC, et al.: Embolization of intracranial aneurysms and sickle cell disease. Am J Hematol 2004, 76:83-84.
19. Molyneux A, Kerr I, Stratton I, et al.: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002, 360:1267-1274.
20. Adams RJ: Stroke prevention and treatment in sickle cell disease. Arch Neurol 2001, 58:565-568.
21. Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Eng J Med 1998, 339:5-11.
22. Adams RJ: Lessons from Stroke Prevention Trial in Sickle Cell Anemia (STOP) Study. J Child Neurol 2000, 15:344-349.
23. Wong WY, Powars DR: Overt and incomplete (silent) cerebral infarction in sickle cell anemia: diagnosis and management. Hematol Oncol Clin N Am 2005, 19:839-855.
24. Adams RJ, Brambilla D: Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators: Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005, 353:2769-2778.
25. Cohen AR, Martin MB, Silber JH, et al.: A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992, 79:1657-1661.
26. The Management of Sickle Cell Disease. NIH Publication No. 02-2117. Bethesda, MD: National Institutes of Health; 2002.
27. Brittenham GM, Badman DG: Noninvasive measurement of iron: report of NIDDK workshop. Blood 2003, 101:15-19.
28. Bernaudin F, Verlhac S, Coic L, et al.: Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 2005, 35:242-248.
29. Gulbis B, Haberman D, Dufour D, et al.: Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood 2005, 105:2685-2690.
30. Nietert PJ, Abboud MR, Silverstein MD, et al.: Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 2000, 95:3057-3064.
31. Pegelow CH, Adams RJ, McKie V, et al.: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995, 126:896-899.
32. Stroke with Transfusions Changing to Hydroxyurea (SWiTCH) Trial. http://clinicaltrials.gov/show/nct00122980. Accessed August 8, 2006.
33. Abboud MR, Atweh GF: Prevention and management of strokes in patients with sickle cell disease. Curr Hematol Rep 2006, 5:15-22.
34. Walters MC, Storb R, Patience M, et al.: Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000, 95:1918-1924.
35. Silent Cerebral Infarct Multi-center Clinical Trial. http://clinicaltrials.gov/show/NCT00072761. Accessed August 8, 2006.
36. Aspirin Prophylaxis in Sickle Cell Disease. http://clinicaltrials.gov/ show/nct00178464. Accessed August 8, 2006.
37. SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High-risk Sickle Cell Disease. http://www.clinicaltrials.gov/show/ nct00257543. Accessed August 8, 2006.